Calton & Associates’s T. Rowe Price Blue Chip Growth ETF TCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-5,223
Closed -$260K – 490
2025
Q4
$260K Buy
5,223
+25
+0.5% +$1.24K 0.04% 362
2025
Q3
$254K Hold
5,198
– – 0.04% 360
2025
Q2
$236K Buy
+5,198
New +$211K 0.04% 332
2022
Q2
– Sell
-8,050
Closed -$236K – 346
2022
Q1
$236K Buy
8,050
+149
+2% +$4.3K 0.07% 298
2021
Q4
$261K Buy
7,901
+849
+12% +$28.3K 0.07% 295
2021
Q3
$224K Buy
+7,052
New +$232K 0.05% 355

Other funds holding TCHP

Calton & Associates's TCHP Position: Q1 2026 in Review

Calton & Associates sold out of T. Rowe Price Blue Chip Growth ETF (TCHP) in Q1 2026, closing a stake of 5,223 shares — an estimated $260K sold.

Calton & Associates first reported a position in TCHP in Q3 2021 and held it in 6 quarters. The position peaked at $261K in Q4 2021. 176 funds tracked by Wall St. Rank hold TCHP as of Q1 2026.

  • Calton & Associates reported no remaining T. Rowe Price Blue Chip Growth ETF position as of Q1 2026 after selling out during the quarter.
  • Calton & Associates sold 5,223 T. Rowe Price Blue Chip Growth ETF shares in Q1 2026, an estimated $260K.
  • Calton & Associates first reported a position in T. Rowe Price Blue Chip Growth ETF in Q3 2021 and held it in 6 quarters.
  • Calton & Associates's T. Rowe Price Blue Chip Growth ETF position peaked at $261K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held T. Rowe Price Blue Chip Growth ETF as of Q1 2026.

Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.